These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 14567797)

  • 21. Development of a Novel Phosphorylated AMPK Protection Assay for High-Throughput Screening Using TR-FRET Assay.
    Xu Y; Wang Y; Xu Y; Li J; Liao H; Zhang L; Pang T
    J Biomol Screen; 2015 Aug; 20(7):906-12. PubMed ID: 25956678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts.
    Davis DW; Inoue K; Dinney CP; Hicklin DJ; Abbruzzese JL; McConkey DJ
    Cancer Res; 2004 Jul; 64(13):4601-10. PubMed ID: 15231672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assays.
    Imbert PE; Unterreiner V; Siebert D; Gubler H; Parker C; Gabriel D
    Assay Drug Dev Technol; 2007 Jun; 5(3):363-72. PubMed ID: 17638536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel scaffolds for IκB kinase beta inhibitor via a high-throughput screening TR-FRET assay.
    Oh KS; Lee S; Choi JK; Lee BH
    Comb Chem High Throughput Screen; 2010 Nov; 13(9):790-7. PubMed ID: 20615197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo.
    LaMontagne KR; Butler J; Borowski VB; Fuentes-Pesquera AR; Blevitt JM; Huang S; Li R; Connolly PJ; Greenberger LM
    Angiogenesis; 2009; 12(3):287-96. PubMed ID: 19544081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate-specific conformational regulation of the receptor tyrosine kinase VEGFR2 catalytic domain.
    Solowiej J; Chen JH; Zou HY; Grant SK; Murray BW
    ACS Chem Biol; 2013 May; 8(5):978-86. PubMed ID: 23441851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-throughput TR-FRET assays for identifying inhibitors of LSD1 and JMJD2C histone lysine demethylases.
    Yu V; Fisch T; Long AM; Tang J; Lee JH; Hierl M; Chen H; Yakowec P; Schwandner R; Emkey R
    J Biomol Screen; 2012 Jan; 17(1):27-38. PubMed ID: 21859682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
    Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
    J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms.
    Jin HY; Tudor Y; Choi K; Shao Z; Sparling BA; McGivern JG; Symons A
    SLAS Discov; 2020 Feb; 25(2):215-222. PubMed ID: 31849250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.
    Mendel DB; Laird AD; Xin X; Louie SG; Christensen JG; Li G; Schreck RE; Abrams TJ; Ngai TJ; Lee LB; Murray LJ; Carver J; Chan E; Moss KG; Haznedar JO; Sukbuntherng J; Blake RA; Sun L; Tang C; Miller T; Shirazian S; McMahon G; Cherrington JM
    Clin Cancer Res; 2003 Jan; 9(1):327-37. PubMed ID: 12538485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A homogeneous G protein-coupled receptor ligand binding assay based on time-resolved fluorescence resonance energy transfer.
    Hu LA; Zhou T; Hamman BD; Liu Q
    Assay Drug Dev Technol; 2008 Aug; 6(4):543-50. PubMed ID: 18699727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal.
    Zielinski T; Reichman M; Donover PS; Lowery RG
    Assay Drug Dev Technol; 2016 May; 14(4):240-51. PubMed ID: 27136323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical anti-angiogenesis and anti-tumor activity of SIM010603, an oral, multi-targets receptor tyrosine kinases inhibitor.
    Wang D; Tang F; Wang S; Jiang Z; Zhang L
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):173-83. PubMed ID: 21638122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacodynamic analysis of target inhibition and endothelial cell death in tumors treated with the vascular endothelial growth factor receptor antagonists SU5416 or SU6668.
    Davis DW; Takamori R; Raut CP; Xiong HQ; Herbst RS; Stadler WM; Heymach JV; Demetri GD; Rashid A; Shen Y; Wen S; Abbruzzese JL; McConkey DJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):678-89. PubMed ID: 15701856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of small molecule inhibitors of the mitotic kinase haspin by high-throughput screening using a homogeneous time-resolved fluorescence resonance energy transfer assay.
    Patnaik D; Jun Xian ; Glicksman MA; Cuny GD; Stein RL; Higgins JM
    J Biomol Screen; 2008 Dec; 13(10):1025-34. PubMed ID: 18978305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homogeneous TR-FRET high-throughput screening assay for calcium-dependent multimerization of sorcin.
    Appelblom H; Nurmi J; Soukka T; Pasternack M; Penttilä KE; Lövgren T; Niemelä P
    J Biomol Screen; 2007 Sep; 12(6):842-8. PubMed ID: 17579123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis.
    Mahabeleshwar GH; Feng W; Reddy K; Plow EF; Byzova TV
    Circ Res; 2007 Sep; 101(6):570-80. PubMed ID: 17641225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of benzamides and benzamidines as selective inhibitors of VEGFR tyrosine kinases.
    Nakamura H; Sasaki Y; Uno M; Yoshikawa T; Asano T; Ban HS; Fukazawa H; Shibuya M; Uehara Y
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5127-31. PubMed ID: 16893647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and characterization of a constitutively T-loop phosphorylated and active recombinant S6K1: expression, purification, and enzymatic studies in a high capacity non-radioactive TR-FRET Lance assay.
    Zhang WG; Shor B; Yu K
    Protein Expr Purif; 2006 Apr; 46(2):414-20. PubMed ID: 16213157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.